IBD gene therapy (AMT)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIBD gene therapy (AMT)
Drug Alias Nameex vivo gene therapy (AMT)ex vivo gene therapy (Amsterdam Molecular Therapeutics)IBD gene therapy (Amsterdam Molecular Therapeutics)
ClassificationBiologics
Mechanisms of ActionInterleukin-10 modulators
TargetsInterleukin-10
Therapy Area/IndicationsInflammationMultiple SclerosisCrohn Disease +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmsterdam Molecular Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmsterdam Molecular Therapeutics
Active IndicationsN/A
Inactive IndicationsInflammationMultiple SclerosisCrohn Disease +[6] 

Other Information

ATC CodeN/A
Related LinksN/A